Patent intelligence · US
US 9796728
Cyclic carbonate monomer containing double-sulfur five-membered ring functional group, and preparation method thereof
Cyclic carbonate monomer containing double-sulfur five-membered ring functional group, and preparation method thereof
Patent details — US 9796728
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 24, 2017
- Expiration
- Oct 19, 2037
- Claims
- 8
- CPC classes
- A61K, A61K47/34, A61K9/5153
Quick answer
US 9796728 (Cyclic carbonate monomer containing double-sulfur five-membered ring functional group, and preparation method thereof) is held by BrightGene Bio-Medical Technology Co., Ltd.. Status: granted. Granted Oct 24, 2017. Expires Oct 19, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 8
- CPC classes
- A61K, A61K47/34, A61K9/5153
More from BrightGene Bio-Medical Technology Co., Ltd.
Related pharmaceutical patents in our USPTO index.
-
US 12383631
Immune antigen specific IL-18 immunocytokines and uses thereof
granted -
US 12350120
Gum-protecting and teeth-whitening strip and preparation method thereof
granted -
US 12220447
Proteolytic enzyme composition
granted -
US 12215133
GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and use
granted -
US 12173062
Modified TNF-α antibodies and uses thereof
granted -
US 12115136
Fortified CBD oil for treatment of PTSD
granted -
US 12097230
Method and composition for treating post operative conditions
granted -
US 11925686
Materials for phototherapies of ophthalmic diseases
granted
Frequently asked questions
What is US patent 9796728?
US 9796728 (Cyclic carbonate monomer containing double-sulfur five-membered ring functional group, and preparation method thereof) is held by BrightGene Bio-Medical Technology Co., Ltd.. Status: granted. Granted Oct 24, 2017. Expires Oct 19, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9796728?
BrightGene Bio-Medical Technology Co., Ltd. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 57 pharmaceutical patents for this assignee.
When does US 9796728 expire?
Our index shows an expiration date of Oct 19, 2037 (11 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.